Transport of chlorpromazine in the Caco-2 cell permeability assay: A kinetic study

Chemical Research in Toxicology

Volumn 25, Issue 7, 2012, Pages 1442-1451

  Broeders, Jessica J W ^a   Van Eijkeren, Jan C H ^b   Blaauboer, Bas J ^a   Hermens, Joop L M ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CHLORPROMAZINE; PLASTIC;

ARTICLE; BASOLATERAL MEMBRANE; CELL MEMBRANE PERMEABILITY; CELL MEMBRANE TRANSPORT; CELL STRAIN CACO 2; CONCENTRATION (PARAMETERS); DRUG ABSORPTION; HYDROPHOBICITY; LIPOPHILICITY; SECRETORY TRANSPORT; SOLID PHASE MICROEXTRACTION; TRANSPORT KINETICS;

ABSORPTION; BIOLOGICAL TRANSPORT; CACO-2 CELLS; CELL MEMBRANE PERMEABILITY; CHLORPROMAZINE; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; KINETICS; SERUM ALBUMIN; SOLID PHASE MICROEXTRACTION;

EID: 84863895887     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/tx300221k     Document Type: Article

References (38)

1. Goodman, L. S. and Gilman, A. G. (2006) Goodman & Gilman's The Pharmacological Basis of Therapeutics, McGraw-Hill, New York.
2. Artursson, P. and Karlsson, J. (1991) Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (CACO-2) cells Biochem. Biophys. Res. Commun. 175, 880-885
3. Sambuy, Y., De Angelis, I., Ranaldi, G., Scarino, M. L., Stammati, A., and Zucco, F. (2005) The Caco-2 cell line as a model of the intestinal barrier: Influence of cell and culture-related factors on Caco-2 cell functional characteristics Cell Biol. Toxicol. 21, 1-26
4. Hubatsch, I., Ragnarsson, E. G. E., and Artursson, P. (2007) Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers Nat. Protoc. 2, 2111-2119
5. Neuhoff, S., Artursson, P., Zamora, I., and Ungell, A.-L. (2006) Impact of extracellular protein binding on passive and active drug transport across Caco-2 cells Pharm. Res. 23, 350-359
6. Saha, P. and Kou, J. H. (2002) Effect of bovine serum albumin on drug permeability estimation across Caco-2 monolayers Eur. J. Pharm. Biopharm. 54, 319-324
7. Yamashita, S., Furubayashi, T., Kataoka, M., Sakane, T., Sezaki, H., and Tokuda, H. (2000) Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells Eur. J. Pharm. Sci. 10, 195-204
8. Ingels, F., Deferme, S., Destexhe, E., Oth, M., Van Den Mooter, G., and Augustijns, P. (2002) Simulated intestinal fluid as transport medium in the Caco-2 cell culture model Int. J. Pharm. 232, 183-192
9. Ingels, F., Beck, B., Oth, M., and Augustijns, P. (2004) Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers Int. J. Pharm. 274, 221-232
10. Heringa, M. B., Schreurs, R. H. M. M., Busser, F., Van Der Saag, P. T., Van Der Burg, B., and Hermens, J. L. M. (2004) Toward more useful in vitro toxicity data with measured free concentrations Environ. Sci. Technol. 38, 6263-6270
11. Gülden, M., Mörchel, S., Tahan, S., and Seibert, H. (2002) Impact of protein binding on the availability and cytotoxic potency of organochlorine pesticides and chlorophenols in vitro Toxicology 175, 201-213
12. Katneni, K., Charman, S. A., and Porter, C. J. H. (2008) Use of plasma proteins as solubilizing agents in in vitro permeability experiments: Correction for unbound drug concentration using the reciprocal permeability approach J. Pharm. Sci. 97, 209-224
13. Fisher, J. M., Wrighton, S. A., Calamia, J. C., Shen, D. D., Kunze, K. L., and Thummel, K. E. (1999) Midazolam metabolism by modified Caco-2 monolayers: Effects of extracellular protein binding J. Pharmacol. Exp. Ther. 289, 1143-1150
14. Katneni, K., Charman, S. A., and Porter, C. J. H. (2006) Permeability assessment of poorly water-soluble compounds under solubilizing conditions: The reciprocal permeability approach J. Pharm. Sci. 95, 2170-2185
15. Arthur, C. L. and Pawliszyn, J. (1990) Solid phase microextraction with thermal desorption using fused silica optical fibers Anal. Chem. 62, 2145-2148
16. Vaes, W. H. J., Urrestarazu Ramos, E., Verhaar, H. J. M., Seinen, W., and Hermens, J. L. M. (1996) Measurement of the free concentration using solid-phase microextraction: Binding to protein Anal. Chem. 68, 4463-4467
17. Heringa, M. B. and Hermens, J. L. M. (2003) Measurement of free concentrations using negligible depletion-solid phase microextraction (nd-SPME) TrAC-Trends Anal. Chem. 22, 575-587
18. Vuckovic, D., Zhang, X., Cudjoe, E., and Pawliszyn, J. (2010) Solid-phase microextraction in bioanalysis: New devices and directions J. Chromatogr., A 1217, 4041-4060
19. Broeders, J. J. W., Blaauboer, B. J., and Hermens, J. L. M. (2011) Development of a negligible depletion-solid phase microextraction method to determine the free concentration of chlorpromazine in aqueous samples containing albumin J. Chromatogr., A 1218, 8529-8535
20. Sawada, G. A., Ho, N. F. H., Williams, L. R., Barsuhn, C. L., and Raub, T. J. (1994) Transcellular permeability of chlorpromazine demonstrating the roles of protein binding and membrane partitioning Pharm. Res. 11, 665-673
21. Aungst, B. J., Nguyen, N. H., Bulgarelli, J. P., and Oates-Lenz, K. (2000) The influence of donor and reservoir additives on Caco-2 permeability and secretory transport of HIV protease inhibitors and other lipophilic compounds Pharm. Res. 17, 1175-1180
22. Yeung, P. K.-F., Hubbard, J. W., Korchinski, E. D., and Midha, K. K. (1993) Pharmacokinetics of chlorpromazine and key metabolites Eur. J. Clin. Pharmacol. 45, 563-569
23. Whitfield, L. R., Kaul, P. N., and Clark, M. L. (1978) Chlorpromazine metabolism. IX. Pharmacokinetics of chlorpromazine following oral administration in man J. Pharmacokinet. Biopharm. 6, 187-196
24. Sandström, R., Karlsson, A., and Lennernäs, H. (1998) The absence of stereoselective P-glycoprotein-mediated transport of R/S-verapamil across the rat jejunum J. Pharm. Pharmacol. 7, 729-735
25. Boulton, D. W., DeVane, C. L., Liston, H. L., and Markowitz, J. S. (2002) In vitro P-glycoprotein affinity for atypical and conventional antipsychotics Life Sci. 2, 163-169
26. Troutman, M. D. and Thakker, D. R. (2003) Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium Pharm. Res. 20, 1210-1224
27. Brown, D., Goosen, T. C., Chetty, M., and Hamman, J. H. (2003) Effect of oral contraceptives on the transport of chlorpromazine across the CACO-2 intestinal epithelial cell line Eur. J. Pharm. Biopharm. 56, 159-165
28. Skolnik, S., Lin, X., Wang, J., Chen, X., He, T., and Zhang, B. (2010) Towards prediction of in vivo intestinal absorption using a 96-well Caco-2 assay J. Pharm. Sci. 99, 3246-3265
29. Palmgrén, J. J., Mönkkönen, J., Korjamo, T., Hassinen, A., and Auriola, S. (2006) Drug adsorption to plastic containers and retention of drugs in cultured cells under in vitro conditions Eur. J. Pharm. Biopharm. 64, 369-378
30. Sun, H., Chow, E. C. Y., Liu, S., Du, Y., and Pang, K. S. (2008) The Caco-2 cell monolayer: Usefulness and limitations Expert Opin. Drug Metab. Toxicol 4, 395-411
31. Carrière, V., Lesuffleur, T., Barbat, A., Rousset, M., Dussaulx, E., Costet, P., De Waziers, I., Beaune, P., and Zweibaum, A. (1994) Expression of cytochrome P-450 in HT29-MTX cells and Caco-2 clone TC7 FEBS Lett. 355, 247-250
32. Heikkinen, A. T., Mönkkönen, J., and Korjamo, T. (2009) Kinetics of cellular retention during Caco-2 permeation experiments: Role of lysosomal sequestration and impact on permeability estimates J. Pharmacol. Exp. Ther. 328, 882-892
33. Krishna, G., Chen, K., Lin, C., and Nomeir, A. A. (2001) Permeability of lipophilic compounds in drug discovery using in-vitro human absorption model, Caco-2 Int. J. Pharm. 222, 77-89
34. Liu, T., Chang, L., Uss, A., Chu, I., Morrison, R. A., Wang, L., Prelusky, D., Cheng, K., and Li, C. (2010) The impact of protein on Caco-2 permeability of low mass balance compounds for absorption projection and efflux substrate identification J. Pharm. Biomed. Anal. 51, 1069-1077
35. Tamai, I., Saheki, A., Saitoh, R., Sai, Y., Yamada, I., and Tsuji, A. (1997) Nonlinear intestinal absorption of 5-hydroxytryptamine receptor antagonist caused by absorptive and secretory transporters J. Pharmacol. Exp. Ther. 283, 108-115
36. Hilgendorf, C., Ahlin, G., Seithel, A., Artursson, P., Ungell, A., and Karlsson, J. (2007) Expression of thirthy-six drug transporter genes in human intestine, liver, kidney and organotypic cell lines Drug Metab. Dispos. 35, 1333-1340
37. Calcagno, A. M., Ludwig, J. A., Fosterl, J. M., Gottesman, M. M., and Ambudkar, S. V. (2006) Comparison of drug transporter levels in normal colon, colon cancer and Caco-2 cells: impact on drug disposition and discovery Mol. Pharmaceutics 3, 87-93
38. Schreiber, S. L., Kapoor, T., and Wess, G., Eds. (2007) Chemical Biology: From Small Molecules to Systems Biology and Drug Design, Vol. 3, Wiley VHC, Weinheim, Germany.